Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.46
Price to sales ratio

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4514
GNTA
Genenta Science S.p.A. - American Depositary Shares
1.05 USD+6.06%-17.32%-33.54%-72.15%24.60 M USD
4517
ENLV
Enlivex Ltd. - Ordinary Shares
1.40 USD-5.41%-4.11%-38.86%+34.62%22.16 M USD
4527
DYAI
Dyadic International, Inc. - Common Stock
0.62 USD-3.13%-10.14%-42.06%-31.11%22.59 M USD
4532
ALLR
Allarity Therapeutics, Inc. - Common stock
1.41 USD+2.17%-0.70%+13.71%-17.06%22.43 M USD

Frequently asked questions about Jasper Therapeutics, Inc. Common Stock

What is the Jasper Therapeutics, Inc. Common Stock stock price today?

The current price of Jasper Therapeutics, Inc. Common Stock (JSPR) is 0.67. Over the past 24 hours, the stock has changed by -4.29%. Follow the JSPR chart for real-time price dynamics.

What is the stock ticker of Jasper Therapeutics, Inc. Common Stock?

Jasper Therapeutics, Inc. Common Stock trades under the ticker JSPR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Jasper Therapeutics, Inc. Common Stock stock going up?

JSPR has changed by -4.29% over the last week, +6.35% over the last month, and -76.41% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Jasper Therapeutics, Inc. Common Stock?

Jasper Therapeutics, Inc. Common Stock currently has a market capitalization of 22.29 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Jasper Therapeutics, Inc. Common Stock earnings last quarter?

Last quarter, Jasper Therapeutics, Inc. Common Stock reported earnings of -0.1 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Jasper Therapeutics, Inc. Common Stock net income for the last quarter?

Jasper Therapeutics, Inc. Common Stock reported net income of -2.76 M for the last quarter. The previous quarter showed -1.17 M, which means net income changed by -135.09%.

How many employees does Jasper Therapeutics, Inc. Common Stock have?

As of the latest available data, Jasper Therapeutics, Inc. Common Stock has 22 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Jasper Therapeutics, Inc. Common Stock stock?

You can buy Jasper Therapeutics, Inc. Common Stock (JSPR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Jasper Therapeutics, Inc. Common Stock stock?

Investing in Jasper Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the JSPR chart and related analysis on metatrader.com as part of your research.

News